Rho A Regulates Epidermal Growth Factor-Induced Human Osteosarcoma MG63 Cell Migration

Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP-2/9 production via the p38 MAPK signaling pathway

(2016) Gong Cheng et al.   Molecular Medicine Reports

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance

(2015) Florian Sevelda et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Hepatic Ischemic Preconditioning Provides Protection Against Distant Renal Ischemia and Reperfusion Injury in Mice

(2012) Jung Ah Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma

(2011) J. H. W. Pahl et al.   CLINICAL CANCER RESEARCH

Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation

(2010) Claude Laflamme et al.   ARCHIVES OF ORAL BIOLOGY

Rac and Rho GTPases in cancer cell motility control

(2010) Matteo Parri et al.   Cell Communication and Signaling

Rho kinase inhibition in diabetic nephropathy

(2010) Radko Komers   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Epidermal Growth Factor Stimulates Human Trophoblast Cell Migration through Rho A and Rho C Activation

(2010) Jian Han et al.   ENDOCRINOLOGY

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

(2009) Shuh Narumiya et al.   CANCER AND METASTASIS REVIEWS

Copy number gains inEGFRand copy number losses inPTENare common events in osteosarcoma tumors

(2008) Serena S. Freeman et al.   CANCER